POLYFRAX_Drosophila is the preclinical multidisciplinary study which examines the effects of polyphenols on Drosophila fragile X model as an alternative model for research on neurodevelopmental disorder known as Fragile X syndrome.
Project info
Title: “Polyphenols as potential targeted treatments in Drosophila melanogaster model of fragile X syndrome”
Acronym: POLYFRAX_Drosophila
Grant Number: 7673781
Principal Investigator: Prof. Dr. Dragana Protic, MD, PhD
Institution: Institute of Pharmacology, Clinical Pharmacology and Toxicology; Faculty of Medicine, University of Belgrade, Serbia
Address: Dr Subotica starijeg 1/III, Belgrade 11129, Serbia
This research is supported by the Science Fund of the Republic of Serbia, Program IDEA #GRANT № 7673781, “Polyphenols as potential targeted treatments in Drosophila melanogaster model of fragile X syndrome”, POLYFRAX_Drosophila.
